Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphoseek for lymph node mapping in pediatric solid tumors
NCT02509598Phase 2Completed
- Sponsor
- Cardinal Health
- Start
- Aug 2015
- Primary completion
- Mar 2019
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of technetium tc 99m tilmanocept in melanoma, rhabdomyosarcoma (RMS), solid tumor, sponsored by Cardinal Health. Started Aug 2015; status: completed.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
melanomarhabdomyosarcoma (RMS)solid tumor
Beyond the preview
Go deeper on NCT02509598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509598.